Skip to main contentAll experts

Vijayendran Chandran

RES ASO PROF

MD-PEDIATRICS

Orcid identifier0000-0002-2469-6263 (opens in a new tab)⁠
  • RES ASO PROF
    MD-PEDIATRICS

GRANTS

  • GRANT
    Development and Validation of Efficacy Biomarkers for QTE Therapy in Friedreich's Ataxia
    National Institute of Health Ninds7 May 2026 - 31 Aug 2026
    Active
  • GRANT
    Optimization and Preclinical Validation of QTE Therapy for Friedreich's Ataxia
    National Institute of Health Ncats7 Jul 2025 - 30 Jun 2027
    Active
  • GRANT
    Understanding Tissue-Specific Reversibility in Friedreich's Ataxia
    Friedreichs Ataxia Research Alliance1 Dec 2019 - 30 Nov 2021
    Expired
  • GRANT
    Regulation of iron-sulfur proteins during frataxin knockdown
    Agios Pharmaceuticals Inc16 Jan 2019 - 15 Sep 2019
    Expired
  • GRANT
    Frataxin mRNA and protein expression
    Biomarin Pharmaceutical18 Dec 2018 - 17 Dec 2021
    Expired
  • GRANT
    MIN-102 therapy in frataxin knock down mouse model of Friedreich's ataxia.
    Minoryx Therapeutics25 Jun 2018 - 30 Jun 2019
    Expired
  • GRANT
    Effect of early and late intervention of frataxin restoration in frataxin knockdown mouse model
    Friedreichs Ataxia Research Alliance27 Nov 2017 - 31 Dec 2019
    Expired
  • GRANT
    Integrating omics approaches to identify biomarkers in Friedreich’s Ataxia
    Muscular Dystrophy Association19 Jan 2017 - 31 Jan 2020
    Expired